Search research articles
Contact Us
Filters
Showing results (231-240 of 314) with videos related to
Page
of 32
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
June 10, 2022
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment
Katarzyna Furrer, Walter Weder, Eric Innocents Eboulet, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 30, 2026
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors
Joseph T Duffy, Angela Martin-Regalado, Benedikt E Haupt, et al.
Cancer Medicine
|
September 29, 2020
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
Tobias Kessler, Anne Berberich, Ahmed Sadik, et al.
Acta Neuropathologica Communications
|
November 3, 2023
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results
Matthew McCord, Pouya Jamshidi, Vineeth Thirunavu, et al.
The Journal of Experimental Medicine
|
September 29, 2020
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
Catalina Lee-Chang, Jason Miska, David Hou, et al.
The Lancet. Oncology
|
July 17, 2009
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
Roger Stupp, Michael Mayer, Roger Kann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
Pratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2011
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Gianfranco A Pesce, Dirk Klingbiel, Karin Ribi, et al.
JCI Insight
|
December 26, 2024
Endothelial response to blood-brain barrier disruption in the human brain
Andrew Gould, Yu Luan, Ye Hou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial
Daniel C Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch, et al.
Page
of 32
Search research articles
Search
Showing results (231-240 of 314) with videos related to
Sort By:
Page
of 32
The Journal of Thoracic and Cardiovascular Surgery
|
June 10, 2022
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment
Katarzyna Furrer, Walter Weder, Eric Innocents Eboulet, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 30, 2026
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors
Joseph T Duffy, Angela Martin-Regalado, Benedikt E Haupt, et al.
Cancer Medicine
|
September 29, 2020
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
Tobias Kessler, Anne Berberich, Ahmed Sadik, et al.
Acta Neuropathologica Communications
|
November 3, 2023
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results
Matthew McCord, Pouya Jamshidi, Vineeth Thirunavu, et al.
The Journal of Experimental Medicine
|
September 29, 2020
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
Catalina Lee-Chang, Jason Miska, David Hou, et al.
The Lancet. Oncology
|
July 17, 2009
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
Roger Stupp, Michael Mayer, Roger Kann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
Pratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2011
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Gianfranco A Pesce, Dirk Klingbiel, Karin Ribi, et al.
JCI Insight
|
December 26, 2024
Endothelial response to blood-brain barrier disruption in the human brain
Andrew Gould, Yu Luan, Ye Hou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial
Daniel C Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch, et al.
Page
of 32